Vitamin D receptor signaling and its therapeutic implications: Genome-wide structural view1

Canadian Journal of Physiology and Pharmacology

Volumn 93, Issue 5, 2015, Pages 311-318

  Carlberg, Carsten ^a   Molnár, Ferdinand ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Chromatin immunoprecipitation; Crystal structure; VDR partner proteins; Vitamin D; Vitamin D analogs; Vitamin D signaling in vivo

Indexed keywords

VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; PROTEIN BINDING;

CHROMATIN; GENETIC ASSOCIATION; HUMAN; IN VIVO STUDY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; TRENDS;

ANIMALS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION;

EID: 84928893035     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/cjpp-2014-0383     Document Type: Review

References (69)

1. Bouillon, R., and Suda, T. 2014 Vitamin D: calcium and bone homeostasis during evolution. BoneKEy Rep. 3 doi:10.1038/bonekey.2013.214 PMID:24466411
2. Bouillon, R., Okamura, W.H., and Norman, A.W. 1995 Structure–function relationships in the vitamin D endocrine system. Endocr.Rev. 16: 200–257 doi: 10.1210/er.16.2.200, 10.1210/edrv-16-2-200 PMID:7781594
3. Carlberg, C. 2003 Molecular basis of the selective activity of vitamin D analogues. J. Cell. Biochem. 88: 274–281 doi:10.1002/jcb.10337 PMID:12520526
4. Carlberg, C. 2014a. Genome-wide (over)view on the actions of vitamin D. Front. Physiol. 5: 167 doi:10.3389/fphys.2014.00167 PMID:24808867
5. Carlberg, C. 2014b. The physiology of vitamin D-far more than calcium and bone. Front.Physiol. 5: 335 doi:10.3389/fphys.2014.00335 PMID:25228886
6. Carlberg, C., and Campbell, M.J. 2013 Vitamin D receptor signaling mechanisms: Integrated actions of a well-defined transcription factor. Steroids, 78: 127–136 doi:10.1016/j.steroids.2012.10.019 PMID:23178257
7. Carlberg, C., and Molnár, F. 2012 Current status of vitamin D signaling and its therapeutic applications. Curr. Top. Med. Chem. 12: 528–547 doi:10.2174/ 156802612799436623 PMID:22242854
8. Carlberg, C., Bendik, I., Wyss, A., Meier, E., Sturzenbecker, L.J., Grippo, J.F., and Hunziker, W. 1993 Two nuclear signalling pathways for vitamin D. Nature, 361: 657–660 doi:10.1038/361657a0 PMID:8382345
9. Carlberg, C., Molnar, F., and Mourino, A. 2012 Vitamin D receptor ligands: the impact of crystal structures. Expert Opin. Ther. Pat. 22: 417–435 doi:10.1517/ 13543776.2012.673590 PMID:22449247
10. Carlberg, C., Seuter, S., de Mello, V.D., Schwab, U., Voutilainen, S., Pulkki, K., et al. 2013 Primary vitamin D target genes allow a categorization of possible benefits of vitamin D3 supplementation. PLoS One, 8: e71042 doi:10.1371/ journal.pone.0071042 PMID:23923049
11. Cheskis, B., and Freedman, L.P. 1994 Ligand modulates the conversion of DNAbound vitamin D3 receptor (VDR) homodimers into VDR-retinoid X receptor heterodimers. Mol. Cell. Biol. 14: 3329–3338 doi:10.1128/MCB.14.5.3329 PMID:8164684
12. Cheskis, B.J., Freedman, L.P., and Nagpal, S. 2006 Vitamin D receptor ligands for osteoporosis. Curr. Opin. Investig. Drugs, 7: 906–911 PMID:17086935
13. Chun, R.F., Liu, P.T., Modlin, R.L., Adams, J.S., and Hewison, M. 2014 Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front. Physiol. 5: 151 doi:10.3389/fphys.2014.00151 PMID:24795646
14. Ciesielski, F., Sato, Y., Chebaro, Y., Moras, D., Dejaegere, A., and Rochel, N. 2012 Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor. J. Med. Chem. 55: 8440–8449 doi:10.1021/ jm300858s. PMID:22957834
15. DeLuca, H.F. 2004 Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80: 1689S–1696S. PMID:15585789
16. Ding, N., Yu, R.T., Subramaniam, N., Sherman, M.H., Wilson, C., Rao, R., et al. 2013 A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell, 153: 601–613 doi:10.1016/j.cell.2013.03.028 PMID:23622244
17. Eelen, G., Valle, N., Sato, Y., Rochel, N., Verlinden, L., De Clercq, P., et al. 2008 Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. Chem. Biol. 15: 1029–1034 doi:10.1016/j.chembiol.2008.08. 008 PMID:18940664
18. ENCODE-Project-Consortium; Bernstein, B.E., Birney, E., Dunham, I., Green, E.D., Gunter, C., and Snyder, M. 2012 An integrated encyclopedia of DNA elements in the human genome. Nature, 489: 57–74 doi:10.1038/ nature11247 PMID:22955616
19. Evans, R.M., and Mangelsdorf, D.J. 2014 Nuclear receptors, RXR, and the Big Bang. Cell, 157: 255–266 doi:10.1016/j.cell.2014.03.012 PMID:24679540
20. Feldman, D., Krishnan, A.V., Swami, S., Giovannucci, E., and Feldman, B.J. 2014 The role of vitamin D in reducing cancer risk and progression. Nat. Rev. Cancer, 14: 342–357 doi:10.1038/nrc3691 PMID:24705652
21. Giresi, P.G., Kim, J., McDaniell, R.M., Iyer, V.R., and Lieb, J.D. 2007 FAIRE (formaldehyde- assisted isolation of regulatory elements) isolates active regulatory elements from human chromatin. Genome Res. 17: 877–885 doi:10.1101/gr. 5533506 PMID:17179217
22. Handel, A.E., Sandve, G.K., Disanto, G., Berlanga-Taylor, A.J., Gallone, G., Hanwell, H., et al. 2013 Vitamin D receptor ChIP-seq in primary CD4+ cells: relationship to serum 25-hydroxyvitamin D levels and autoimmune disease. BMC Med. 11: 163 doi:10.1186/1741-7015-11-163 PMID:23849224
23. Haussler, M.R., Haussler, C.A., Jurutka, P.W., Thompson, P.D., Hsieh, J.C., Remus, L.S., et al. 1997 The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J. Endocrinol. 154(Suppl.): S57–S73 doi:10.1677/joe.0.154S057 PMID:9379138
24. Heikkinen, S., Väisänen, S., Pehkonen, P., Seuter, S., Benes, V., and Carlberg, C. 2011 Nuclear hormone 1a,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 39: 9181–9193 doi:10.1093/nar/gkr654 PMID:21846776
25. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., et al. 2010 Simple combinations of lineage-determining transcription factors prime cisregulatory elements required for macrophage and B cell identities. Mol. Cell, 38: 576–589 doi:10.1016/j.molcel.2010.05.004 PMID:20513432
26. Herdick, M., Bury, Y., Quack, M., Uskokovic, M.R., Polly, P., and Carlberg, C. 2000 Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists. Mol. Pharmacol. 57: 1206–1217 PMID:10825392
27. Hochberg, Z., and Templeton, A.R. 2010 Evolutionary perspective in skin color, vitaminDand its receptor. Hormones (Athens), 9: 307–311 doi:10.14310/horm. 2002.1281 PMID:21112861
28. Holick, M.F. 2007 Vitamin D deficiency. N. Engl. J. Med. 357: 266–281 doi:10. 1056/NEJMra070553 PMID:17634462
29. Holick, M.F. 2011 Vitamin D: evolutionary, physiological and health perspectives. Curr. Drug Targets, 12: 4–18 doi:10.2174/138945011793591635 PMID: 20795941
30. Hollis, B.W. 2005 Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr. 135: 317–322 PMID:15671234
31. Institute-of-Medicine. 2011 Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, D.C.
32. Liu, M., Lee, M.-H., Cohen, M., Bommakanti, M., and Freedman, L.P. 1996. Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10: 142–153 doi:10.1101/gad.10.2.142 PMID:8566748
33. Makishima, M. 2005 Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors. J. Pharmacol. Sci. 97: 177–183 doi:10.1254/jphs.FMJ04008X4 PMID:15725701
34. Malinen, M., Saramäki, A., Ropponen, A., Degenhardt, T., Väisänen, S., and Carlberg, C. 2008 Distinct HDACs regulate the transcriptional response of human cyclin-dependent kinase inhibitor genes to trichostatin A and 1a,25- dihydroxyvitamin D3. Nucleic Acids Res. 36: 121–132 PMID:17999998
35. Marks, P.A., Richon, V.M., Breslow, R., and Rifkind, R.A. 2001 Histone deacetylase inhibitors as new cancer drugs. Curr. Opin. Oncol. 13: 477–483 doi:10. 1097/00001622-200111000-00010 PMID:11673688
36. Masuno, H., Ikura, T., Morizono, D., Orita, I., Yamada, S., Shimizu, M., and Ito, N. 2013 Crystal structures of complexes of vitamin D receptor ligand-binding domain with lithocholic acid derivatives. J. Lipid Res. 54: 2206–2213 doi:10. 1194/jlr.M038307 PMID:23723390
37. Meyer, M.B., Goetsch, P.D., and Pike, J.W. 2012 VDR/RXR and TCF4/b-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 26: 37–51 doi:10.1210/me.2011-1109 PMID:22108803
38. Molnar, F. 2014 Structural considerations of vitamin D signaling. Front. Physiol. 5: 191 doi:10.3389/fphys.2014.00191 PMID:24936188
39. Molnár, F., Peräkylä, M., and Carlberg, C. 2006 Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket. J. Biol. Chem. 281: 10516–10526 doi:10.1074/jbc.M513609200 PMID:16478719
40. Monneret, C. 2005 Histone deacetylase inhibitors. Eur. J. Med. Chem. 40: 1–13 doi:10.1016/j.ejmech.2004.10.001 PMID:15642405
41. Norman, A.W. 2008 From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am. J. Clin. Nutr. 88: 491S-499S. PMID:18689389
42. Novershtern, N., Subramanian, A., Lawton, L.N., Mak, R.H., Haining, W.N., McConkey, M.E., et al. 2011 Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell, 144: 296–309 doi:10.1016/ j.cell.2011.01.004 PMID:21241896
43. Orlando, V. 2000 Mapping chromosomal proteins in vivo by formaldehydecrosslinked- chromatin immunoprecipitation. Trends Biochem. Sci. 25: 99–104 doi:10.1016/S0968-0004(99)01535-2 PMID:10694875
44. Orlov, I., Rochel, N., Moras, D., and Klaholz, B.P. 2012 Structure of the full human RXR/VDR nuclear receptor heterodimer complex with its DR3 target DNA. EMBO J. 31: 291–300 doi:10.1038/emboj.2011.445 PMID:22179700
45. Park, P.J. 2009 ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet. 10: 669–680 doi:10.1038/nrg2641, 10.1038/ni0709-669 PMID: 19736561
46. Polly, P., Herdick, M., Moehren, U., Baniahmad, A., Heinzel, T., and Carlberg, C. 2000 VDR-Alien: a novel, DNA-selective vitamin D3 receptor–corepressor partnership. FASEB J. 14: 1455–1463 doi:10.1096/fj.14.10.1455 PMID:10877839
47. Ramagopalan, S.V., Heger, A., Berlanga, A.J., Maugeri, N.J., Lincoln, M.R., Burrell, A., et al. 2010 A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20: 1352–1360 doi:10.1101/gr.107920.110 PMID:20736230
48. Robinson, J.T., Thorvaldsdottir, H., Winckler, W., Guttman, M., Lander, E.S., Getz, G., and Mesirov, J.P. 2011 Integrative genomics viewer. Nat. Biotechnol. 29: 24–26 doi:10.1038/nbt.1754 PMID:21221095
49. Rochel, N., Wurtz, J.M., Mitschler, A., Klaholz, B., and Moras, D. 2000 Crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol. Cell, 5: 173–179 doi:10.1016/S1097-2765(00)80413-X. PMID:10678179
50. Ryynänen, J., Neme, A., Tuomainen, T.P., Virtanen, J.K., Voutilainen, S., Nurmi, T., et al. 2014 Changes in vitamin D target gene expression in adipose tissue monitor the vitamin D response of human individuals. Mol. Nutr. Food Res. 58: 2036–2045 doi:10.1002/mnfr.201400291 PMID:24975273
51. Schräder, M., Bendik, I., Becker-Andre, M., and Carlberg, C. 1993 Interaction between retinoic acid and vitamin D signaling pathways. J. Biol. Chem. 268: 17830–17836 PMID:8394351
52. Schräder, M., Müller, K.M., Nayeri, S., Kahlen, J.P., and Carlberg, C. 1994 VDRT3R receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature, 370: 382–386 doi:10.1038/370382a0 PMID:8047145
53. Schräder, M., Nayeri, S., Kahlen, J.P., Müller, K.M., and Carlberg, C. 1995 Natural vitamin D3 response elements formed by inverted palindromes: polaritydirected ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Mol. Cell. Biol. 15: 1154–1161 PMID: 7862109
54. Schulman, I.G., Li, C., Schwabe, J.W., and Evans, R.M. 1997 The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev. 11: 299–308 doi:10.1101/gad.11.3.299 PMID:9030683
55. Seuter, S., Heikkinen, S., and Carlberg, C. 2013a. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1a,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. Nucleic Acids Res. 41: 110–124 doi:10.1093/nar/gks959 PMID: 23093607
56. Seuter, S., Pehkonen, P., Heikkinen, S., and Carlberg, C. 2013b. Dynamics of 1a,25-dihydroxyvitamin D-dependent chromatin accessibility of early vitamin D receptor target genes. Biochim. Biophys. Acta, 1829: 1266–1275doi: 10.1016/j.bbagrm.2013.10.003 PMID:24185200
57. Shaffer, P.L., and Gewirth, D.T. 2002 Structural basis of VDR–DNA interactions on direct repeat response elements. EMBO J. 21: 2242–2252 doi:10.1093/emboj/ 21.9.2242 PMID:11980721
58. Shaffer, P.L., and Gewirth, D.T. 2004 Structural analysis of RXR–VDR interactions on DR3 DNA. J. Steroid Biochem. Mol. Biol. 89–90: 215–219 doi:10.1016/ j.jsbmb.2004.03.084 PMID:15225774
59. Sone, T., Ozono, K., and Pike, J.W. 1991 A 55-kilodalton accessory factor facilitates vitamin D receptor DNA binding. Mol. Endocrinol. 5: 1578–1586 doi:10. 1210/mend-5-11-1578 PMID:1664043
60. Toropainen, S., Väisänen, S., Heikkinen, S., and Carlberg, C. 2010 The downregulation of the human MYC gene by the nuclear hormone 1a,25- dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J. Mol. Biol. 400: 284–294 doi:10.1016/j.jmb.2010.05.031 PMID: 20493879
61. Tuoresmäki, P., Väisänen, S., Neme, A., Heikkinen, S., and Carlberg, C. 2014 Patterns of genome-wide VDR locations. PLoS One, 9: e96105 doi:10.1371/ journal.pone.0096105 PMID:24787735
62. Umesono, K., Murakami, K.K., Thompson, C.C., and Evans, R.M. 1991 Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell, 65: 1255–1266 doi:10.1016/0092-8674 (91)90020-Y. PMID:1648450
63. Vaisanen, S., Perakyla, M., Karkkainen, J.I., Uskokovic, M.R., and Carlberg, C. 2003 Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor. Mol. Pharmacol. 63: 1230–1237 doi:10.1124/mol.63.6.1230 PMID:12761332
64. Vaquerizas, J.M., Kummerfeld, S.K., Teichmann, S.A., and Luscombe, N.M. 2009 A census of human transcription factors: function, expression and evolution. Nat. Rev. Genet. 10: 252–263 doi:10.1038/nrg2538 PMID:19274049
65. Virtanen, J.K., Nurmi, T., Voutilainen, S., Mursu, J., and Tuomainen, T.P. 2011 Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur. J. Nutr. 50: 305–312 doi:10.1007/s00394-010- 0138-3 PMID:20976461
66. Wang, Y., Zhu, J., and DeLuca, H.F. 2012 Where is the vitamin D receptor? Arch. Biochem. Biophys. 523: 123–133 doi:10.1016/j.abb.2012.04.001 PMID:22503810
67. Warrener, R., Beamish, H., Burgess, A., Waterhouse, N.J., Giles, N., Fairlie, D., and Gabrielli, B. 2003 Tumor cell-selective cytotoxicity by targeting cell cycle checkpoints. FASEB J. 17: 1550–1552 PMID:12824307
68. Wilfinger, J., Seuter, S., Tuomainen, T.-P., Virtanen, J.K., Voutilainen, S., Nurmi, T., et al. 2014 Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system. J. Nutr. Biochem. 25: 875–884 doi:10.1016/j.jnutbio.2014.04.002 PMID:24854954
69. Zaret, K.S., and Carroll, J.S. 2011 Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25: 2227–2241 doi:10.1101/ gad.176826.111 PMID:22056668.